- Home
- QURE vs TXO Comparison
QURE vs TXO Comparison
Compare QURE & TXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QURE
- TXO
- Stock Information
- Founded
- QURE 1998
- TXO 2012
- Country
- QURE Netherlands
- TXO United States
- Employees
- QURE N/A
- TXO N/A
- Industry
- QURE Biotechnology: Pharmaceutical Preparations
- TXO Oil & Gas Production
- Sector
- QURE Health Care
- TXO Energy
- Exchange
- QURE Nasdaq
- TXO Nasdaq
- Market Cap
- QURE 725.4M
- TXO 806.1M
- IPO Year
- QURE 2007
- TXO 2023
- Fundamental
- Price
- QURE $17.27
- TXO $15.12
- Analyst Decision
- QURE Strong Buy
- TXO
- Analyst Count
- QURE 10
- TXO 0
- Target Price
- QURE $37.20
- TXO N/A
- AVG Volume (30 Days)
- QURE 1.4M
- TXO 466.2K
- Earning Date
- QURE 07-31-2025
- TXO 05-01-2025
- Dividend Yield
- QURE N/A
- TXO 15.72%
- EPS Growth
- QURE N/A
- TXO N/A
- EPS
- QURE N/A
- TXO 0.40
- Revenue
- QURE $20,201,000.00
- TXO $299,696,000.00
- Revenue This Year
- QURE $27.16
- TXO $27.46
- Revenue Next Year
- QURE $248.21
- TXO $4.03
- P/E Ratio
- QURE N/A
- TXO $37.38
- Revenue Growth
- QURE 6.30
- TXO 3.43
- 52 Week Low
- QURE $3.73
- TXO $14.78
- 52 Week High
- QURE $19.18
- TXO $22.39
- Technical
- Relative Strength Index (RSI)
- QURE 67.53
- TXO 37.16
- Support Level
- QURE $14.75
- TXO $14.78
- Resistance Level
- QURE $15.50
- TXO $15.15
- Average True Range (ATR)
- QURE 1.07
- TXO 0.40
- MACD
- QURE 0.16
- TXO 0.04
- Stochastic Oscillator
- QURE 93.40
- TXO 35.53
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.
About TXO TXO Partners L.P.
TXO Partners LP is focused on the acquisition, development, optimization, and exploitation of oil, natural gas, and natural gas liquid reserves in North America.